Fundraising Fox

Mountain Group Capital

Family officeoperating company · company profile

Nashville · Pre-Seed–Late Stage · 11 people tracked

Also known as MGC VENTURE PARTNERS 2018 GP, LLC · MGP VENTURE FUND III GP, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Mountain Group Capital invests in healthcare and technology, deliberately targeting unique, often overlooked segments within these industries rather than mainstream venture opportunities. The firm takes an active, hands-on role in shaping companies from their earliest stages and emphasizes a 'come early, stay late' philosophy. Drawing on its family office roots, it maintains a patient, long-term outlook and positions itself as a reliable partner regardless of how long a company's journey takes.

Source: firm website, verified Aug 25, 2026.

Stage
Pre-Seed–Late Stage
HQ
Nashville, US
Instruments
Equity
Founded
1999
Private fund assets
$140.3M
VC funds
2
Tracked investments
36

Team · 11 people

from the firm's website & public directories

What they invest in

from 30 of 36 portfolio companies

Healthtech ×19Biotech ×17Medical Devices ×11Digital Health ×9AI & Machine Learning ×6AgTech ×5FoodTech ×3Hardware ×3

HQs:United States×28

Who they back

founder profiles across 15 portfolio companies
67%
solo founders
10 of 15 mapped founding teams

Founding team size:solo founder×102 founders×33 founders×14+ founders×1

Investments · 36 tracked

founders shown can be your intro path

By year:2025 · 12024 · 12023 · 12022 · 12016 · 12015 · 22013 · 18 dated

AN2 Therapeuticsan2therapeutics.cominNASDAQ: ANTX

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.

BiotechHealthtechMenlo Park, US

Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Margaret FitzPatrick(Director)Patricia Martin(Director)

Co-investorsAdjuvant CapitalBioRock VenturesFlucas VenturesRA CapitalHatteras Venture Partners

Castle Biosciencescastlebiosciences.comin𝕏NASDAQ: CSTL

Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.

BiotechDigital HealthHealthtechFriendswood, US

Derek Maetzold(Executive Officer, Director)inDerek J. Maetzold(Founder, President & Chief Executive Officer)Frank Stokes(Chief Financial Officer)Kristen Oelschlager(Chief Operating Officer)Toby Juvenal(Chief Commercial Officer)Hillary Caruso(Chief of Staff)

Co-investorsBioBritIllumina Ventures

Corcept Therapeuticscorcept.cominNASDAQ: CORT

Corcept develops cortisol modulators — molecules that regulate cortisol activity at the glucocorticoid receptor — to treat serious diseases across endocrinology, oncology, metabolism, and neurology.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsLongitude Capital

5Metis5metis.comin

5Metis is a discovery-stage company developing boron-based molecules for crop protection, running medicinal/discovery chemistry and toxicity testing programs to invent new agricultural active ingredients.

AgTechBiotechNew MaterialsResearch Triangle Park, US

Brian Green(Co-founder, CEO & CSO)inSteven L.K. Tuttle(Executive Officer, Director)Richard Gianni(Executive Officer)Steve Tuttle(COO & Board Member)

BoardYogesh Mago(Director)Cindy Smith(Director)

Co-investors1855 Capital PartnersOspraie Ag Science

Advanced Animal Diagnosticsqscoutlab.comin𝕏

QScout Lab provides rapid, on-farm diagnostic tests for livestock producers to detect diseases and guide treatment decisions.

AgTechMedical Devices

Co-investorsWolfpack Investor Network

Airvetairvet.com

Beverly Hills, US

Brandon Werber(Executive Officer, Director)Eliyahu Ben-Ezra(Executive Officer)Roy Rubin(Director)Asher Leids(Director)

BoardWilliam Su(Director)David Shadpour(Director)

Co-investorsCanvas VenturesHawke VenturesPath VenturesStarting Line75 & SunnyBracket Capital+3 more

AngelEye Healthangeleye.health

Neonatal and pediatric family support technology company

HealthtechNashville, US

Christopher Rand(Executive Officer, Director)Curtis Lowery(Director)

BoardEmily Rash(Director)Alex Whitmore(Director)Gerard Hayden, Jr.(Director)Byron Smith(Director)in

Co-investorsSeedToB

Appello Pharmaceuticalsappellopharma.comJan 2022

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesNashville, US

Dr. Laden(Co-founder)Christopher Rand(Executive Officer)Vaughn Bryson(Director)Jeff P. Conn(Director)

BoardWilliam Slattery(Director)Howie Furst(Director)in

Co-investorsRelevance VenturesDeerfield Management Company

Aspire Healthaspirehealthcare.cominacquired by CareMore Health (Anthem)

Nashville-based provider of home and outpatient community-based palliative care for seriously ill patients, acquired by Anthem in 2018.

Digital HealthHealthtechNashville, US

Brad Smith(Executive Officer, Director)Andrew Lasher(Executive Officer)Diane Seloff(Executive Officer)William Anderson(Executive Officer)William Frist(Director)

BoardAnn Lamont(Director)

Co-investorsFrist Cressey VenturesGV (Google Ventures)Lifeforce CapitalOak HC/FT

Borah

Identifying and developing boronized molecules for use in animal health.

Cerebrotechcerebrotechmedical.com
Circular Genomicscirculargenomics.comin𝕏

Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.

AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US

Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)

Co-investorsCottonwood Technology FundTramway Venture Partners

Clearside Biomedicalclearsidebio.comin

Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.

BiotechHealthtechMedical DevicesAlpharetta, US

Mark Prausnitz(Director)Charles Deignan(Executive Officer)Glenn Noronha(Executive Officer)Daniel H. White(Executive Officer, Director)

BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in

Co-investorsHEALTHCARE ROYALTY PARTNERSSolasta VenturesHatterasHatteras Venture Partners

Contego Medicalcontegomedical.comin

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Co-investorsLightstone VenturesHatteras Venture PartnersAmzak HealthUS Venture Partners

Ethosethossystems.comin𝕏

Ethos Systems provides an AI-driven training platform that delivers personalized, role-specific learning content and ties training to performance data for readiness measurement.

AI & Machine LearningDefense TechEdTech

Andrew Powell(Founder)inSasha Seymore(Founder)in

Co-investorsDorm RoomJ4 VenturesMVP VenturesNorwest Venture PartnersTech Square VenturesCubit Capital

EvermindinMay 2013

Nashville, US

David A. Gilbert(Executive Officer, Director)Paul Griffin(Executive Officer)Don Stratton(Executive Officer)

BoardChristopher Rand(Director)Jeff Landman(Director)Michael Burcham(Director)

Exubrionsynovetin.comin𝕏

Exubrion Therapeutics develops veterinary therapies using conversion electron therapy from Tin-117m to treat pain and inflammation in companion animals.

BiotechHealthtechMedical Devices

G1 Therapeuticsg1therapeutics.comFeb 2015

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

BiotechResearch Triangle Park, US

Mark A. Velleca(Executive Officer, Director)inTimothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)Seth Rudnick(Director)Ron Laufer(Director)Michael Gutch(Director)

Co-investorsLumira VenturesRA CapitalSolasta VenturesHatteras Venture Partners

In the Bowl Animal Healthinthebowlah.comJun 2024

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.

BiotechConsumerFoodTechHealthtechNashville, US

Randolph Legg(Chief Executive Officer)Scott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)

Co-investorsBioBrit

Ironwood Pharmaceuticalsironwoodpharma.comin𝕏Sep 2016

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.

BiotechDigital HealthHealthtechCambridge, US

PETER M. HECHT(Executive Officer, Director)MARK G. CURRIE(Executive Officer)HALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)

BoardTERRANCE G. MCGUIRE(Director)

Co-investorsF-Prime CapitalRidgeback CapitalVenrockMaverick VenturesPolaris Partners

LineaGenlineagen.comin𝕏Jan 2015

Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications.

BiotechDigital HealthHealthtechMedical DevicesSalt Lake City, US

Gayland Moffat(Executive Officer)Michael S. Paul(Executive Officer, Director)

BoardMichael Fitzgerald(Director)Fred A. Middleton(Director)Mary C. Tanner(Director)Michael Walsh(Director)

Mindera Healthminderahealth.comin𝕏

Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology.

AI & Machine LearningBiotechDigital HealthMedical DevicesVista, US

Tahir Mahmood(Executive Officer, Director)Philippe ` Nore(Executive Officer, Director)

BoardAndrew Offer(Director)inTyler Whitmore(Director)inJoseph C. Cook III(Director)Patrick Rivelli(Director)

Co-investorsScientific Health Development

NeuroTronik

HealthtechDurham, US

R. Frederick McCoy, Jr.(Executive Officer, Director)

BoardMudit Jain(Director)Douglas Reed(Director)

Nusirt Sciencesnusirt.com

NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension.

BiotechHealthtechLongevityNashville, US

Michael Zemel(Executive Officer, Director)Barbara Cannon(Executive Officer)Joseph C. Cook, Jr.(Executive Officer, Director)

BoardEric Satz(Director)Vaughn Bryson(Director)Brian Laden(Director)

Co-investorsHatteras Venture Partners

Overdog

Nashville, US

Steven Berneman(Executive Officer, Director)Hunter Hillenmeyer(Executive Officer, Director)

BoardStuart Larkins(Director)inEric Satz(Director)

Co-investorsChicago VenturesAtlas Venture

PhaseBio Pharmaceuticalsphasebio.com

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Executive Officer, Director)

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Co-investorsNew Enterprise Associates (NEA)Hatteras Venture Partners

Pinkdxpinkdx.comin𝕏Sep 2023

PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.

BiotechDigital HealthFemTechIndianapolis, US

Richard T. Kloos(Chief Medical Officer)Timothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Co-Founder and Chief Scientific Officer)Isaac Ro(Director)Risa Stack(Director)Eric Wang(Executive Officer)

Reactive Bioreactivebio.com

Co-investorsCanaan Partners

ReVIDA Recovery Centersrevidarecovery.comin

ReVIDA Recovery operates a network of outpatient recovery centers that treat opioid use disorder using Medication Assisted Treatment (MAT) and a multi-disciplinary behavioral healthcare approach.

Digital HealthHealthtechMental HealthNortheast Tennessee, US

Silicon Ranchsiliconranch.comin

Swap Robotics builds 100% electric autonomous robots for utility-scale solar sites, handling vegetation management, solar panel laying during construction, and materials movement.

CleantechClimate TechEnergyRoboticsNashville, US

Matthew Beasley(Executive Officer, Director)Philip Bredesen(Director)David Reagan Farr(Executive Officer, Director)Matthew H. Kisber(Executive Officer, Director)Michael Payne(Executive Officer)Philip N. Bredesen(Director)

Co-investorsManulife Investment Management

Targantargan.comin𝕏

TARGAN is an animal agtech systems company that engineers precision technologies for commercial food producers, with a focus on sustainability and animal welfare.

AgTechAI & Machine LearningFoodTechHardwareRaleigh, US

Co-investorsOval Park Capital

Value Payment Systemsvaluepaymentsystems.comin𝕏

Value Payment Systems (operating as Catalis) provides payment processing and collection solutions for government agencies and public sector organizations including courts, tax offices, utilities, and child support agencies.

FintechGovTechSaaSNashville, US

Velo-1Jul 2025

HealthtechNashville, US

David Rosen(Executive Officer, Director)

BoardAtsushi Nagahisa(Director)Robin Readnour(Director)Scott Holmstrom(Director)inLynne Zydowsky(Director)

Verilityverilityco.comin

Verility builds Fertile-Eyez, an AI-based image analysis and optical sensor platform for point-of-care fertility testing in animals, assessing sperm quality and predicting ovulation phase.

AgTechAI & Machine LearningHardwareHealthtech

Liane Hart(CEO & Co-Founder)Hadi Shafiee(Inventor, Co-Founder, & Technical Advisor)Brian Kopp(CFO & Head of Business Strategy)Scott Baxter(Chief Product Officer)

Vets First Choicevetsfirstchoice.comin

Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.

HealthtechMedical DevicesSaaS

Co-investorsHarbor Light Capital Partners

Vytellevytelle.comin

Vytelle offers an integrated technology platform for cattle producers to accelerate genetic progress and enable individual animal management.

AgTechBiotechFoodTechSaaSLenexa, US

Kerryann Kocher(Executive Officer, Director)Rudy Leemans(Executive Officer)

BoardDuane Cantrell(outgoing director)inJim Schultz(Director)Robin Readnour(Director)James (Jim) Shafter(outgoing director)

Co-investorsFulcrum Global CapitalKCRise FundSerra Ventures

Exits · 4

IPOs and acquisitions across the tracked portfolio

AN2 TherapeuticsNASDAQ: ANTXCastle BiosciencesNASDAQ: CSTLCorcept TherapeuticsNASDAQ: CORTAspire Healthacq. by CareMore Health (Anthem)

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Mountain Group Capital made?
Mountain Group Capital has 35 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
What stage does Mountain Group Capital invest at?
Mountain Group Capital invests at the Pre-Seed, Seed, Late Stage stages.
What sectors does Mountain Group Capital focus on?
Mountain Group Capital focuses on AgTech, AI & Machine Learning, Biotech, Digital Health, Energy, Enterprise Software, Healthtech, Medical Devices, SaaS.
Where is Mountain Group Capital located?
Mountain Group Capital is headquartered in Nashville, US.
Who does Mountain Group Capital co-invest with?
Mountain Group Capital most often shares deals with BioBrit, RA Capital, Solasta Ventures, among 43 tracked co-investors.

Images

Mountain Group Capital photo

Co-investors · 8

Canvas Ventures

Canvas Prime (formerly Canvas Ventures) is an early-stage venture capital firm that invests in AI transforming digital health and fintech, leading Series A and B rounds in companies ready to scale.

Both backed · 1
$5M – $20M
FJ Labs

FJ Labs is an early-stage investment firm specializing in marketplaces and network-effect businesses, taking an angel-style co-investment approach alongside institutional venture funds worldwide.

$100K – $3M
Atomico

Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.

500 Global

500 Global (formerly 500 Startups) is a venture capital firm whose flagship Silicon Valley strategy backs promising technology companies from pre-seed onward across a range of sectors and geographies.

$150K
Presight Capital

Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.

$500K – $20M
Race Capital

Race Capital is an early-stage venture fund that invests in companies operating in data, enterprise, infrastructure, and fintech sectors.

$250K – $2M
L Catterton

L Catterton Growth is the growth investing arm of L Catterton, a consumer-focused private equity group that has made over 300 investments in consumer brands since 1989. The firm manages roughly $40 billion and backs middle-market companies and emerging high-growth consumer businesses; this unit is listed with a London office.

$10M – $200M
Angel Ventures Mexico

Angel Ventures (AV) is a Mexican venture capital firm investing in early-stage to early-growth companies across Latin America, acting as a lead Series Seed and Series A investor in startups with business models tailored for the Latin American market.

$250K – $1M

Firms observed investing alongside Mountain Group Capital, from public investor directories. Shared companies are the overlap with Mountain Group Capital's recorded portfolio.

Similar investors

Featured in lists